跳至主要内容
临床试验/NCT05976971
NCT05976971已完成不适用

Microstructural Brain MRI Biomarkers in Patients With Idiopathic REM Sleep Behaviour Disorder at 7 Tesla

Assistance Publique Hopitaux De Marseille2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2023年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
2
主要终点
3D cartography difference of Fractional anisotropy between the iRBD and control subjects

研究概览

简要总结

By 2030 the number of patients with Parkinson's Disease (PD) would increase by 56% affecting 1 out of 120 people older than 45 years-old. It is known that 10-15 years before the onset motor symptoms such as tremor, rigidity and akinesia, patients often experience a specific sleep trouble called REM sleep behaviour disorder (RBD). Follow-up of those subjects showed there was a conversion rate to PD and related disorders (called synucleinopathies) over 80%.

The pathophysiology of RBD is poorly understood. The development of cutting-edge technologies such as 7 Tesla MRI and the optimisation of image processing methods made it possible to non-invasively explore in vivo small brain structures involved in sleep and movement disorders.

The investigators hypothesize that brain and brainstem microstructure, composition, sodium homeostasis and connectivity may change in 15 isolated RBD (iRBD) subjects compared with 15 healthy controls and that these changes may be correlated with clinical scores.

This study would help fill the gap in early diagnosis of synucleinopathies, by contributing to better targeting patients who could be included in therapeutic trials with a neuroprotective effect. Besides, the exploration of original pathophysiological pathways such as sodium homeostatis could provide the necessary arguments for the development of new target therapeutics.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • for patients with REM Sleep Behaviour Disorder :
  • Patient aged between 40 and 80 years old
  • Patient fulfilling the diagnostic criteria for RBD (International Classification of Sleep Disorders version 3, American Academy of Sleep Medicine, 2014) with polysomnographic confirmation (which will be carried out as part of the routine work-up);
  • UPDRS Part III score under or equal to 5
  • The patient is enrolled in the French social security system
  • The patient understood and signed the consent to participate in the study.
  • Inclusion Criteria for control group :
  • Patient aged between 40 and 80 years old
  • Score under or equal 4 for the RBD screening questionnaire
  • UPDRS Part III score under or equal 5
  • The patient is enrolled in the French social security system
  • The patient understood and signed the consent to participate in the study.

排除标准

  • Patient / Subject with a history of central nervous system disease (e.g. PD, Alzheimer's disease, stroke, brain tumour, multiple sclerosis, amyotrophic lateral sclerosis, etc.). If a doubt exist, this criterion will be left to the judgement of the principal investigator, who is a neurologist.
  • Contraindications to 7T MRI: presence of a metal in the body or in the eye, patient with a pacemaker or neurostimulator, cochlear implants or any implanted electronic medical equipment in general, metallic heart valve, aneurysm clips.
  • Claustrophobia.
  • Montreal Cognitive Assessment Test (MOCA) < 25/30
  • Pregnant or breast-feeding woman or protected person (under guardianship, curatorship, deprived of liberty).

结局指标

主要结局

3D cartography difference of Fractional anisotropy between the iRBD and control subjects

时间窗: Time of the Inclusion

Fractional anisotropy between 0 and 1

3D cartography difference of Mean diffusivity between the iRBD and control subjects

时间窗: Time of the Inclusion

Mean diffusivity in mm2/s

3D cartography the rate of difference of atrophy between the idiopathic REM Sleep Behaviour Disorder (iRBD) and control subjects

时间窗: Time of the Inclusion

Voxel based morphometry evaluated with Matlab and SnPM

3D cartography difference of neuromelanin between the iRBD and control subjects with T1 sequence

时间窗: Time of the Inclusion

Neuromelanin contrast ratio

3D cartography difference of neuromelanin between the iRBD and control subjects with Magnetization transfert sequence

时间窗: Time of the Inclusion

Magnetization transfert contrast ratio

3D cartography the rate of difference of Quantitative Susceptibility Mapping between the iRBD and control subjects

时间窗: Time of the Inclusion

Iron load evaluation in ppb

次要结局

  • 3D cartography difference of total sodium concentration between the iRBD and control subjects(Time of the Inclusion)
  • 3D cartography difference of structural brain connectivity between the iRBD and control subjects(Time of the Inclusion)
  • Rate of Dependency between MRI parameters and demographic data(Time of the Inclusion)
  • Rate of Dependency between MRI parameters and demographic data, clinical scores/questionnaires(Time of the Inclusion)
  • Rate of Dependency between MRI parameters and clinical scores/questionnaires(Time of the Inclusion)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验